|
End-of-day quote
Shanghai S.E.
18/08/2026
|
5-day change | 1st Jan Change | ||
| 12.72 CNY | -4.43% |
|
+8.53% | +8.72% |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 05-25 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 5.15B 765M 659M 620M 564M 1.06B 73.14B 1.08B 7.28B 2.85B 36.57B 2.87B 2.81B 122B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.5B 816M 704M 662M 602M 1.13B 78.09B 1.15B 7.77B 3.04B 39.04B 3.06B 3B 130B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -4.43% | ||
| 1 week | +8.53% | ||
| Current month | +23.74% | ||
| 1 month | +16.16% | ||
| 3 months | +4.52% | ||
| 6 months | +6.18% | ||
| Current year | +8.72% |
| 1 week | 12.49 | 13.71 | |
| 1 month | 9.51 | 13.71 | |
| Current year | 9.51 | 17.46 | |
| 1 year | 9.51 | 17.46 | |
| 3 years | 9.51 | 20.34 | |
| 5 years | 9.51 | 21.28 | |
| 10 years | 8.82 | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 26/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 31/08/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 31/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 28/02/2018 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 28/02/2018 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 27/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 02/08/24 | Buy | Director | 13,000 | 0.0032% | ||
| 05/08/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.43% | +8.53% | -2.53% | -20.30% | 799M | ||
| +3.60% | -0.50% | +74.80% | +127.97% | 1,055B | ||
| +3.33% | +3.55% | +53.48% | +55.80% | 632B | ||
| +3.43% | +4.42% | +25.27% | +72.59% | 442B | ||
| +1.35% | -3.27% | +40.98% | +39.91% | 351B | ||
| +1.75% | -0.98% | +26.20% | +39.73% | 290B | ||
| +2.13% | -1.53% | +1.85% | +9.40% | 243B | ||
| +1.41% | +1.94% | +43.45% | +61.18% | 227B | ||
| +1.35% | -3.20% | -9.07% | -53.51% | 200B | ||
| +3.25% | +7.80% | +21.18% | +87.50% | 172B | ||
| Average | +1.01% | -1.20% | +27.56% | +42.03% | 361.33B | |
| Weighted average by Cap. | +1.30% | -1.87% | +43.72% | +68.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 318M 275M 258M 235M 442M 30.46B 449M 3.03B 1.19B 15.23B 1.2B 1.17B 50.81B | 1.7B 253M 218M 205M 186M 351M 24.19B 357M 2.41B 942M 12.09B 949M 929M 40.35B |
| Net income | 274M 40.69M 35.09M 32.98M 30.01M 56.43M 3.89B 57.44M 387M 152M 1.95B 153M 149M 6.49B | 46.25M 6.87M 5.92M 5.57M 5.07M 9.52M 657M 9.69M 65.38M 25.58M 329M 25.79M 25.22M 1.1B |
| Net Debt | 108M 15.99M 13.79M 12.96M 11.79M 22.17M 1.53B 22.57M 152M 59.53M 765M 60.02M 58.71M 2.55B | 349M 51.78M 44.65M 41.96M 38.19M 71.8M 4.95B 73.09M 493M 193M 2.48B 194M 190M 8.26B |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | CN¥12.72 | -4.43% | 18,524,153 |
| 17/08/26 | CN¥13.31 | -1.63% | 23,809,024 |
| 14/08/26 | CN¥13.53 | +4.64% | 29,785,385 |
| 13/08/26 | CN¥12.93 | +2.62% | 18,411,600 |
| 12/08/26 | CN¥12.60 | -0.40% | 25,392,910 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
















